Infographic. Number of sterile syringes distributed per person who injects drugs and proportion of high-risk opioid users in opioid agonist treatment (OAT)

This graphic is part of the Elimination barometer on viral hepatitis among people who inject drugs in Europe (prevention component).

Figure. Number of sterile syringes distributed per person who injects drugs and proportion of high-risk opioid users in opioid agonist treatment (OAT), by country, 2019 or latest available data

Source data

Table 6. Number of sterile syringes distributed per person who injects drugs and proportion of high-risk opioid users in opioid substitution treatment (OST), by country, 2019 or latest available data (source data for Figure 6)
Country People who inject drugs, year of estimate Number people who inject drugs High-risk opioid use, year of estimate Number high-risk opioid users Total number of syringes distributed Total number of OST clients Proportion in OST Syringes per person who injects drugs
Croatia 2015 6344 2015 8874 234487 5061 0.57 37
Cyprus 2019 637 2019 1022 878 277 0.27 1
Czechia 2019 40800 2019 10500 7459123 5000 0.48 183
Finland 2017 25000 2017 26200 5800000 3329 0.13 232
France 2019 129703 2019 202485 12840577 177100 0.87 99
Greece 2019 3287 2019 14753 464745 9708 0.66 141
Hungary 2015 6707 2010-11 3244 188696 715 0.22 28
Latvia 2016 7715 2017 7100 720494 669 0.09 93
Lithuania 2016 8868 2016 7503 240061 1231 0.16 27
Luxembourg 2018 800 2018 1470 492704 1117 0.76 616
Norway 2018 8269 2013 9015 3.00E+06 7055 0.78 363
Portugal 2015 13162 2018 28287 1004706 17246 0.61 76
Spain 2018 10341 2018 64983 1812069 58447 0.9 175
Belgium 2019 7018 NA NA NA NA 0.72 178

Originally published in:

Elimination barometer on viral hepatitis among people who inject drugs in Europe

Main subject

drug-related infectious diseases

Keywords

#ResponsesGuide
harm reduction
health and social responses
hepatitis B
hepatitis C
injecting drug use
needle and syringe provision
OAT (opioid agonist treatment)
treatment monitoring

Target audience

policymaker
researcher

Media type:

infographics

Published date:

November 2021
CC-BY-4.0
Download (0.13 MB)

Related assets in the Media library

graph showing incidence of HCV seroprevalence among injecting drug users in Europe
Infographic: HCV antibody prevalence among people who inject drugs: seroprevalence studies and diagnostic test results with national and subnational coverage, 2017-18

Media library

Loading